Growth-stage medtech investors in the UK
Growth-stage companies are raising larger rounds to scale, usually led by later-stage funds, with early investors often still holding. Medical device and diagnostics companies often combine grant funding with angel and specialist fund rounds, with regulatory milestones shaping when they raise. 18 investor-backed growth-stage medtech companies are in Pulse, and 1 raised a first funding round in the last year.
- Investor-backed companies
- 18
- Active investors, 2 years
- 125
- Rounds, 2 years
- 27
- Median round
- £2.19m
Who is investing
In the last two years 24 funds, firms and family offices and 101 angels took shares in growth-stage medtech companies, with the latest round in Sep 2026. These are the firms backing the most of these companies:
| Firm | Type | Companies |
|---|---|---|
| Built Holdings Limited | Holding company (possible family office) | 4 companies |
| The Chancellor, Masters and Scholars of the University of Oxford | University | 3 companies |
| Octopus Future Generations VCT PLC | Fund or investment firm | 2 companies |
| Octopus Ventures | Fund or investment firm | 2 companies |
| 3B Capital Partners, Inc. | Fund or investment firm | 1 company |
| Ansor Fund I GP LLP (in Its Capacity As General Partner of Ansor Fund I LP) | Fund or investment firm | 1 company |
| Arch Venture | Fund or investment firm | 1 company |
| Artis Ventures | Fund or investment firm | 1 company |
See all 125 active investors, including angels, with what they've backed, estimated cheque sizes and who they invest alongside.
Rounds and valuations
Over the last two years, 27 funding rounds were raised by growth-stage medtech companies, an estimated £290.6m, with a median round of about £2.19m. 1 of the companies raised their first priced round in the last 12 months. 22% of these valuations carry a High confidence rating.
How Medtech compares
Medtech companies make up 0% of the 74,284 investor-backed companies in Pulse. The median round of £2.19m is above the £176k median for the whole UK market. The most active firm in these companies is Built Holdings Limited, in 4 companies.
Questions
How many investors back growth-stage medtech companies?
Pulse found 125 outside investors taking shares in growth-stage medtech companies in the last two years: 24 funds, firms and family offices, and 101 angels.
How much do growth-stage medtech companies raise?
Over the last two years 27 rounds were raised, an estimated £290.6m in total. The median round was about £2.19m.
How accurate are the amounts?
They are Pulse estimates, each with a confidence rating. 22% of recent valuations here carry a High confidence rating; the rest are marked Medium or Low.
Can I see every investor?
Pulse subscribers see every outside investor by name, with portfolios and co-investors, from £39.99 a month plus VAT (£47.99 inc. VAT). Contact details are not included and names are not linked to personal profiles.